Literature DB >> 28084500

[Pros and cons of antipsychotic drugs in Prodromal stages of schizophrenia].

S Weinmann1, V Aderhold2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28084500     DOI： 10.1007/s00115-016-0274-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  12 in total

1.  Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.

Authors:  Antonio Preti; Matteo Cella
Journal:  Schizophr Res       Date:  2010-08-21       Impact factor: 4.939

2.  [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro].

Authors:  M Lambert; C Correll
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

3.  Deconstructing the Psychosis Risk Syndrome: Moving the Field of Prevention Forward.

Authors:  Barbara A Cornblatt; Ricardo E Carrión
Journal:  JAMA Psychiatry       Date:  2016-02       Impact factor: 21.596

Review 4.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 5.  Minimal evidence that untreated psychosis damages brain structures: a systematic review.

Authors:  Kelly K Anderson; Myanca Rodrigues; Kamalpreet Mann; Aristotle Voineskos; Benoit H Mulsant; Tony P George; Kwame J McKenzie
Journal:  Schizophr Res       Date:  2015-01-30       Impact factor: 4.939

6.  EPA guidance on the early intervention in clinical high risk states of psychoses.

Authors:  S J Schmidt; F Schultze-Lutter; B G Schimmelmann; N P Maric; R K R Salokangas; A Riecher-Rössler; M van der Gaag; A Meneghelli; M Nordentoft; M Marshall; A Morrison; A Raballo; J Klosterkötter; S Ruhrmann
Journal:  Eur Psychiatry       Date:  2015-03-03       Impact factor: 5.361

7.  Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

Authors:  Nancy C Andreasen; Dawei Liu; Steven Ziebell; Anvi Vora; Beng-Choon Ho
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

8.  A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.

Authors:  Tyler A Lesh; Costin Tanase; Benjamin R Geib; Tara A Niendam; Jong H Yoon; Michael J Minzenberg; J Daniel Ragland; Marjorie Solomon; Cameron S Carter
Journal:  JAMA Psychiatry       Date:  2015-03       Impact factor: 21.596

Review 9.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

10.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Steven Ziebell; Ronald Pierson; Vincent Magnotta
Journal:  Arch Gen Psychiatry       Date:  2011-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.